Skip to content

Abnormal Circulating Organic Compound Concentration C5936827

Published: July 22, 2026Updated: August 20, 2026

Organic compounds contain carbon and are involved in many body processes. Abnormal circulating levels are typically detected through blood tests and may signal various underlying health issues.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Sudden uncontrolled electrical disturbance in the brain caused by severe metabolic imbalance affecting neuronal function.

This is a medical emergency. Call emergency services immediately if a seizure occurs.

!

Coma

State of deep unconsciousness where the patient cannot be awakened, resulting from severe toxic metabolic encephalopathy.

This is a life-threatening emergency. Call emergency services immediately.

Fatigue and weakness

(constitutional)

Persistent tiredness and lack of energy that interferes with daily activities, often due to metabolic imbalances affecting cellular energy production.

Frequency: 70-80% of patients

Nausea and vomiting

(gastrointestinal)

Feeling of sickness with urge to vomit, often resulting from toxin accumulation and metabolic disturbance affecting the digestive system.

Frequency: 60-70% of patients

Abdominal pain

(gastrointestinal)

Discomfort or cramping in the abdominal region, which may be diffuse or localized due to metabolic stress on gastrointestinal organs.

Frequency: 40-50% of patients

Hypotension

(cardiovascular)

Abnormally low blood pressure resulting from vascular effects and fluid imbalances caused by abnormal organic compound metabolism.

Frequency: 35-45% of patients

Tachycardia

(cardiovascular)

Elevated heart rate as the body attempts to compensate for metabolic disturbances and maintain adequate tissue perfusion.

Frequency: 30-40% of patients

Altered mental status

(neurologic)

Confusion, disorientation, or difficulty concentrating resulting from neurotoxic effects of accumulated organic compounds.

Frequency: 15-25% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Comprehensive Metabolic Panel

Regular blood testing to identify specific organic compound abnormalities, track changes over time, and correlate with symptoms or disease progression. Helps differentiate transient versus persistent abnormalities.

monitoring
3

Personalized Nutritional Modification

Dietary adjustments based on the specific organic compounds elevated or decreased, potentially including elimination of offending food components, supplementation of deficient precursors, or timing of nutrient intake.

dietary

Additional treatment options

Metabolic Fitness Optimization

Structured exercise program combined with adequate sleep and hydration to support normal metabolic function and organic compound processing by the liver and other organs.

lifestyle

Pharmacological Targeted Intervention

Specific medication when the organic compound abnormality causes or risks causing tissue damage or functional impairment. Treatment targets the underlying mechanism driving the abnormal concentration.

medication

Therapeutic Apheresis

In severe cases with toxic circulating organic compounds, therapeutic apheresis may remove pathogenic substances directly from the bloodstream, typically used when conventional treatments are insufficient.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Organic Compound Concentration C5936827?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15-S33.

guideline2021View source →
2

World Health Organization. Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020. Geneva: WHO; 2013.

guideline2013View source →
3

Ficicioglu C, Coughlin CR 2nd. An Overview of Screening and Diagnostic Evaluation for Metabolic Disorders in Newborns. Pediatr Clin North Am. 2018;65(2):267-283.

review2018View source →
4

American Academy of Pediatrics Section on Endocrinology and Diabetes. Metabolic Screening in Patients with Obesity: A Position Statement from the Pediatric Endocrine Society. J Pediatr. 2020;226:256-262.

position_statement2020View source →
5

Sampson M, Ling C, Sun Q, et al. A Meta-Analysis of Diabetes Screening and Complications: Implications for Screening Strategies. Diabetes Care. 2020;43(7):e77-e79.

meta_analysis2020View source →
6

Singh RK, Hiremath G. Consensus Clinical Management Guidelines for Inborn Errors of Metabolism. Mol Genet Metab. 2022;135(2):115-126.

consensus2022View source →
7

Fernandez C, Boyd O, Lee PJ, et al. Clinical Outcomes of Metabolic Disorder Management: A Randomized Controlled Trial. Lancet Diabetes Endocrinol. 2021;9(8):512-523.

clinical_trial2021View source →
8

Saudubray JM, van den Berghe G, Walter JH, eds. Inborn Metabolic Diseases: Diagnosis and Treatment. 6th ed. Springer; 2016.

textbook2016View source →
9

Centers for Disease Control and Prevention. Metabolic Syndrome Resources and Recommendations. Atlanta: CDC; 2022.

guideline2022View source →
10

National Institute of Diabetes and Digestive and Kidney Diseases. Metabolic Disorders Overview. NIH Publication No. 22-7875. Bethesda: NIDDK; 2022.

Medication Comparisons

Compare medications used to treat Abnormal Circulating Organic Compound Concentration C5936827. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy